Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial
在奥地利蒂罗尔州，接种两剂BNT162b2新冠疫苗后的免疫反应以及SARS-CoV-2突破性感染风险：一项开放标签、观察性4期试验
期刊:Lancet Microbe
影响因子:20.4
doi:10.1016/S2666-5247(23)00107-6
Seekircher, Lisa; Bánki, Zoltán; Kimpel, Janine; Rössler, Annika; Schäfer, Helena; Falkensammer, Barbara; Bante, David; Forer, Lukas; Schönherr, Sebastian; Harthaller, Teresa; Sacher, Magdalena; Ower, Cornelia; Tschiderer, Lena; Ulmer, Hanno; Krammer, Florian; von Laer, Dorothee; Borena, Wegene; Willeit, Peter
SARS-CoV-2
新冠
炎症/感染
微生物学
免疫/内分泌
